• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Statistical Alchemy: Conceptual Validity and Mapping to Generate Health State Utility Values.统计炼金术:概念效度与生成健康状态效用值的映射
Pharmacoecon Open. 2017 Dec;1(4):233-239. doi: 10.1007/s41669-017-0027-2.
2
Estimating the relationship between preference-based generic utility instruments and disease-specific quality-of-life measures in severe chronic constipation: challenges in practice.估算基于偏好的通用效用量表与严重慢性便秘特定疾病生命质量测量指标之间的关系:实践中的挑战。
Pharmacoeconomics. 2011 Aug;29(8):719-30. doi: 10.2165/11588360-000000000-00000.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Mapping to obtain EQ-5D utility values for use in NICE health technology assessments.用于 NICE 健康技术评估的 EQ-5D 效用值映射。
Value Health. 2013 Jan-Feb;16(1):202-10. doi: 10.1016/j.jval.2012.10.010.
5
Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.质量调整生命年在儿科护理中缺乏质量:对已发表的儿童健康成本效用研究的批判性综述。
Pediatrics. 2005 May;115(5):e600-14. doi: 10.1542/peds.2004-2127.
6
Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methods.将临床结局映射到通用偏好为基础的结局测量指标:方法的制定与比较。
Health Technol Assess. 2020 Jun;24(34):1-68. doi: 10.3310/hta24340.
7
Challenges in health state valuation in paediatric economic evaluation: are QALYs contraindicated?儿科经济评价中健康状态估值的挑战:QALYs 是否被禁止?
Pharmacoeconomics. 2011 Aug;29(8):641-52. doi: 10.2165/11591570-000000000-00000.
8
Development of the Incontinence Utility Index: estimating population-based utilities associated with urinary problems from the Incontinence Quality of Life Questionnaire and Neurogenic Module.尿失禁效用指数的开发:根据尿失禁生活质量问卷和神经源性模块评估与泌尿系统问题相关的基于人群的效用
Health Qual Life Outcomes. 2014 Oct 8;12:147. doi: 10.1186/s12955-014-0147-7.
9
10
An Updated Systematic Review of Studies Mapping (or Cross-Walking) Measures of Health-Related Quality of Life to Generic Preference-Based Measures to Generate Utility Values.健康相关生活质量测量指标与通用偏好量表关联(或映射)以生成效用值的研究的更新系统评价。
Appl Health Econ Health Policy. 2019 Jun;17(3):295-313. doi: 10.1007/s40258-019-00467-6.

引用本文的文献

1
Cost-Effectiveness of Newborn Screening for X-Linked Adrenoleukodystrophy in the Netherlands: A Health-Economic Modelling Study.荷兰对X连锁肾上腺脑白质营养不良进行新生儿筛查的成本效益:一项卫生经济建模研究。
Int J Neonatal Screen. 2025 Jul 16;11(3):53. doi: 10.3390/ijns11030053.
2
Prediction of the SF-6D utility score from Lung cancer FACT-L: a mapping study in China.从 Lung cancer FACT-L 预测 SF-6D 效用评分:在中国的映射研究。
Health Qual Life Outcomes. 2023 Nov 14;21(1):122. doi: 10.1186/s12955-023-02209-8.
3
Mapping from SIBDQ to EQ-5D-5L for patients with inflammatory bowel disease.将 SIBDQ 映射到炎症性肠病患者的 EQ-5D-5L。
Eur J Health Econ. 2024 Apr;25(3):539-548. doi: 10.1007/s10198-023-01603-9. Epub 2023 Jun 27.
4
Mapping the Peds QL 4.0 onto CHU-9D: a cross-sectional study in functional dyspepsia population from China.将 PedsQL 4.0 映射到 CHU-9D:来自中国功能性消化不良人群的横断面研究。
Front Public Health. 2023 May 31;11:1166760. doi: 10.3389/fpubh.2023.1166760. eCollection 2023.
5
Mapping the World Health Organization Disability Assessment Schedule (WHODAS 2.0) onto SF-6D Using Swedish General Population Data.利用瑞典普通人群数据将世界卫生组织残疾评定量表(WHODAS 2.0)映射到SF-6D上。
Pharmacoecon Open. 2023 Sep;7(5):765-776. doi: 10.1007/s41669-023-00425-y. Epub 2023 Jun 15.
6
Mapping health assessment questionnaire disability index onto EQ-5D-5L in China.在中国将健康评估问卷残疾指数映射到 EQ-5D-5L。
Front Public Health. 2023 Apr 18;11:1123552. doi: 10.3389/fpubh.2023.1123552. eCollection 2023.
7
Obtaining EQ-5D-3L utility index from the health status scale of traditional Chinese medicine (TCM-HSS) based on a mapping study.基于映射研究从中医健康状况量表(TCM-HSS)获取 EQ-5D-3L 效用指数。
Health Qual Life Outcomes. 2022 Dec 15;20(1):164. doi: 10.1186/s12955-022-02076-9.
8
Mapping the obesity problems scale to the SF-6D: results based on the Scandinavian Obesity Surgery Registry (SOReg).将肥胖问题量表映射到 SF-6D:基于斯堪的纳维亚肥胖手术登记处(SOReg)的结果。
Eur J Health Econ. 2023 Mar;24(2):279-292. doi: 10.1007/s10198-022-01473-7. Epub 2022 May 20.
9
Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data.基于 BASDAI 和 BASFI 生成 EQ-5D-5L 健康效用评分:使用英国纵向登记数据的中轴型脊柱关节炎患者的映射研究。
Eur J Health Econ. 2022 Nov;23(8):1357-1369. doi: 10.1007/s10198-022-01429-x. Epub 2022 Feb 3.
10
Mapping the Haem-A-QoL to the EQ-5D-5L in patients with hemophilia.血友病患者中血友病生活质量量表(Haem-A-QoL)与欧洲五维度健康量表(EQ-5D-5L)的映射研究
Qual Life Res. 2022 May;31(5):1533-1544. doi: 10.1007/s11136-021-03051-5. Epub 2021 Nov 30.

本文引用的文献

1
Mapping to Estimate Health-State Utility from Non-Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report.从基于非偏好的结局指标映射估计健康状态效用值:药物经济学与结果研究国际协会(ISPOR)结果研究良好实践专责小组报告
Value Health. 2017 Jan;20(1):18-27. doi: 10.1016/j.jval.2016.11.006.
2
Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement.映射到基于偏好的结局指标的研究的首选报告项目:MAPS声明。
Pharmacoeconomics. 2015 Oct;33(10):985-91. doi: 10.1007/s40273-015-0319-2.
3
The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration.适用于基于通用偏好的结局指标的映射研究的MAPS报告声明:解释与阐述
Pharmacoeconomics. 2015 Oct;33(10):993-1011. doi: 10.1007/s40273-015-0312-9.
4
A comparison of direct and indirect methods for the estimation of health utilities from clinical outcomes.从临床结果估计健康效用的直接方法与间接方法的比较。
Med Decis Making. 2014 Oct;34(7):919-30. doi: 10.1177/0272989X13500720. Epub 2013 Sep 11.
5
Constructing indirect utility models: some observations on the principles and practice of mapping to obtain health state utilities.构建间接效用模型:关于映射获得健康状态效用的原则和实践的一些观察。
Pharmacoeconomics. 2013 Aug;31(8):635-41. doi: 10.1007/s40273-013-0071-4.
6
Mapping from disease-specific to generic health-related quality-of-life scales: a common factor model.从疾病特异性量表到通用健康相关生活质量量表的映射:共同因素模型。
Value Health. 2013 Jan-Feb;16(1):177-84. doi: 10.1016/j.jval.2012.07.003. Epub 2012 Sep 25.
7
Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.使用多发性硬化症影响量表来估算健康状态效用值:从 MSIS-29 版本 2 到 EQ-5D 和 SF-6D 的映射。
Value Health. 2012 Dec;15(8):1084-91. doi: 10.1016/j.jval.2012.07.007. Epub 2012 Nov 4.
8
Mapping analyses to estimate EQ-5D utilities and responses based on Oxford Knee Score.基于牛津膝关节评分的 EQ-5D 效用值和反应的映射分析。
Qual Life Res. 2013 Apr;22(3):683-94. doi: 10.1007/s11136-012-0189-4. Epub 2012 May 4.
9
The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D.使用多发性硬化症特定条件的措施来为卫生政策决策提供信息:从 MSWS-12 到 EQ-5D 的映射。
Mult Scler. 2012 Jun;18(6):853-61. doi: 10.1177/1352458511429319. Epub 2011 Nov 22.
10
Statistical analysis of EQ-5D profiles: does the use of value sets bias inference?EQ-5D 轮廓的统计分析:使用效值体系是否会影响推论?
Med Decis Making. 2010 Sep-Oct;30(5):556-65. doi: 10.1177/0272989X09357473. Epub 2010 Mar 12.

统计炼金术:概念效度与生成健康状态效用值的映射

Statistical Alchemy: Conceptual Validity and Mapping to Generate Health State Utility Values.

作者信息

Round Jeff, Hawton Annie

机构信息

School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.

Health Economics Group, University of Exeter Medical School, University of Exeter, Exeter, UK.

出版信息

Pharmacoecon Open. 2017 Dec;1(4):233-239. doi: 10.1007/s41669-017-0027-2.

DOI:10.1007/s41669-017-0027-2
PMID:29441504
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5711748/
Abstract

Mapping between non-preference- and preference-based health-related quality-of-life instruments has become a common technique for estimating health state utility values for use in economic evaluations. Despite the increased use of mapped health state utility estimates in health technology assessment and economic evaluation, the methods for deriving them have not been fully justified. Recent guidelines aim to standardise reporting of the methods used to map between instruments but do not address fundamental concerns in the underlying conceptual model. Current mapping methods ignore the important conceptual issues that arise when extrapolating results from potentially unrelated measures. At the crux of the mapping problem is a question of validity; because one instrument can be used to predict the scores on another, does this mean that the same preference for health is being measured in actual and estimated health state utility values? We refer to this as conceptual validity. This paper aims to (1) explain the idea of conceptual validity in mapping and its implications; (2) consider the consequences of poor conceptual validity when mapping for decision making in the context of healthcare resource allocation; and (3) offer some preliminary suggestions for improving conceptual validity in mapping.

摘要

在基于非偏好和基于偏好的健康相关生活质量工具之间进行映射,已成为一种用于估计健康状态效用值以进行经济评估的常用技术。尽管在卫生技术评估和经济评估中,映射后的健康状态效用估计值的使用越来越多,但其推导方法尚未得到充分论证。近期的指南旨在规范用于工具间映射方法的报告,但未涉及基础概念模型中的根本问题。当前的映射方法忽略了从潜在不相关测量中推断结果时出现的重要概念问题。映射问题的关键在于有效性问题;因为一种工具可用于预测另一种工具的得分,这是否意味着在实际和估计的健康状态效用值中测量的是对健康的相同偏好?我们将此称为概念有效性。本文旨在:(1)解释映射中概念有效性的概念及其影响;(2)考虑在医疗资源分配背景下进行映射以用于决策时,概念有效性不佳的后果;(3)为提高映射中的概念有效性提供一些初步建议。